[
  [
    1,
    "1 Introduction"
  ],
  [
    2,
    "1.1 Background on Neurotrophic Factors"
  ],
  [
    2,
    "1.2 Importance of Neurotrophic Effects"
  ],
  [
    2,
    "1.3 Objectives of the Literature Survey"
  ],
  [
    1,
    "2 Neurotrophic Factors and Their Mechanisms"
  ],
  [
    2,
    "2.1 Overview of Neurotrophic Factors"
  ],
  [
    3,
    "2.1.1 Brain-Derived Neurotrophic Factor (BDNF)"
  ],
  [
    3,
    "2.1.2 Nerve Growth Factor (NGF)"
  ],
  [
    3,
    "2.1.3 Other Key Neurotrophic Factors"
  ],
  [
    2,
    "2.2 Cellular and Molecular Mechanisms"
  ],
  [
    3,
    "2.2.1 Signal Transduction Pathways"
  ],
  [
    3,
    "2.2.2 Regulation of Gene Expression"
  ],
  [
    3,
    "2.2.3 Interaction with Synaptic Plasticity"
  ],
  [
    1,
    "3 Interventions Targeting Neurotrophic Effects"
  ],
  [
    2,
    "3.1 Pharmacological Interventions"
  ],
  [
    3,
    "3.1.1 Small Molecule Enhancers"
  ],
  [
    3,
    "3.1.2 Peptide-Based Therapeutics"
  ],
  [
    3,
    "3.1.3 Drug Delivery Systems"
  ],
  [
    2,
    "3.2 Non-Pharmacological Interventions"
  ],
  [
    3,
    "3.2.1 Physical Exercise"
  ],
  [
    3,
    "3.2.2 Cognitive Training"
  ],
  [
    3,
    "3.2.3 Dietary Modifications"
  ],
  [
    2,
    "3.3 Emerging Technologies"
  ],
  [
    3,
    "3.3.1 Gene Therapy"
  ],
  [
    3,
    "3.3.2 Stem Cell Therapy"
  ],
  [
    3,
    "3.3.3 Neurostimulation Techniques"
  ],
  [
    1,
    "4 Clinical Applications and Evidence"
  ],
  [
    2,
    "4.1 Neurodegenerative Diseases"
  ],
  [
    3,
    "4.1.1 Alzheimer's Disease"
  ],
  [
    3,
    "4.1.2 Parkinson's Disease"
  ],
  [
    3,
    "4.1.3 Huntington's Disease"
  ],
  [
    2,
    "4.2 Neuropsychiatric Disorders"
  ],
  [
    3,
    "4.2.1 Depression"
  ],
  [
    3,
    "4.2.2 Anxiety Disorders"
  ],
  [
    3,
    "4.2.3 Schizophrenia"
  ],
  [
    2,
    "4.3 Traumatic Brain Injury and Stroke"
  ],
  [
    3,
    "4.3.1 Recovery Mechanisms"
  ],
  [
    3,
    "4.3.2 Intervention Strategies"
  ],
  [
    1,
    "5 Challenges and Limitations"
  ],
  [
    2,
    "5.1 Scientific Gaps in Understanding"
  ],
  [
    3,
    "5.1.1 Complexity of Neurotrophic Pathways"
  ],
  [
    3,
    "5.1.2 Individual Variability in Response"
  ],
  [
    2,
    "5.2 Practical Challenges in Implementation"
  ],
  [
    3,
    "5.2.1 Cost and Accessibility of Interventions"
  ],
  [
    3,
    "5.2.2 Ethical Considerations"
  ],
  [
    3,
    "5.2.3 Long-Term Safety Concerns"
  ],
  [
    1,
    "6 Discussion"
  ],
  [
    2,
    "6.1 Synthesis of Findings"
  ],
  [
    2,
    "6.2 Implications for Future Research"
  ],
  [
    1,
    "7 Conclusion"
  ],
  [
    2,
    "7.1 Summary of Key Points"
  ],
  [
    2,
    "7.2 Final Remarks"
  ]
]